Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NYSE · Healthcare · Financials

Johnson & Johnson (JNJ) financial statements and cash flow.

Revenue, profitability, balance-sheet strength, and cash generation for JNJ. Market data source · as of 2026-06-28.

Section freshness

Price Aug 19, 3:44 PM EDT · Statements Jun 27, 8:00 PM EDT

Financial read

JNJ latest financial snapshot.

Start with the latest reported values below. Deeper quarterly and annual statement tables follow when supplied.

Revenue

$25.31B

+6.6% YoY

Net income

$5.53B

+5.7% QoQ

Gross margin

68.19%

Gross profit $17.26B

Net margin

21.86%

Balance sheet coverage

JNJ balance sheet summary

Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.

20 quarterly · 4 annual rows · Market data source · as of 2026-06-28

Open balance sheet table

Latest period

Q2 FY2026

20 quarterly · 4 annual rows

Assets / liabilities

$201.06B

Liabilities $116.09B

Cash / debt

$20.42B

Net cash -$16.92B

Equity / working capital

$84.97B

Working capital $4.88B

Financial statements

JNJ statement coverage.

Income statement, balance sheet, and cash-flow figures for JNJ, with quarterly and annual history in the tables below.

Data last updated

Jun 27, 2026

Income periods

Balance-sheet periods

Cash-flow periods

Quarterly and annual JNJ statements, sourced from Market data source · as of 2026-06-28.

Financial statement period

JNJ statement history

Market data source · as of 2026-06-28 · Data last updated: Jun 27, 2026

ProfitabilityIncome statementRevenue, expenses, margins, and income quality20 quarterly periods Capital structureBalance sheetAssets, liabilities, debt, equity, and share count20 quarterly periods Cash generationCash flowOperating cash flow, CapEx, FCF, buybacks, and dividends20 quarterly periods

Income statement

Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.

8 / 20 Quarterly

Period	Revenue	Gross profit	Net income	Net margin	Revenue QoQ	Net income QoQ
Q2 FY2026	$25.31B	$17.26B	$5.53B	21.86%	+5.2%	+5.7%
Q1 FY2026	$24.06B	$15.96B	$5.24B	21.76%	-2.0%	+2.3%
Q4 FY2025	$24.56B	$16.60B	$5.12B	20.83%	+2.4%	-0.7%
Q3 FY2025	$23.99B	$16.69B	$5.15B	21.47%	+1.1%	-7.0%
Q2 FY2025	$23.74B	$16.11B	$5.54B	23.32%	+8.5%	-49.7%
Q1 FY2025	$21.89B	$14.54B	$11.00B	50.24%	-2.8%	+220.6%
Q4 FY2024	$22.52B	$15.39B	$3.43B	15.24%	+0.2%	+27.4%
Q3 FY2024	$22.47B	$15.51B	$2.69B	11.99%	+0.1%	-42.5%

Balance sheet

Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.

8 / 20 Quarterly

Period	Cash	Current assets	Current liabilities	Total assets	Total liabilities	Total debt	Total equity	Debt QoQ
Q2 FY2026	$20.42B	$59.77B	$54.90B	$201.06B	$116.09B	$37.34B	$84.97B	-0.5%
Q1 FY2026	$21.69B	$59.17B	$57.72B	$200.89B	$119.71B	$37.53B	$81.19B	-21.7%
Q4 FY2025	$19.71B	$55.62B	$54.13B	$199.21B	$117.67B	$47.94B	$81.54B	+21.6%
Q3 FY2025	$18.23B	$54.61B	$50.87B	$192.82B	$113.54B	$39.41B	$79.28B	+0.4%
Q2 FY2025	$18.58B	$54.50B	$54.18B	$193.39B	$114.92B	$39.23B	$78.47B	+2.3%
Q1 FY2025	$38.47B	$71.55B	$56.90B	$193.67B	$115.56B	$38.35B	$78.11B	+4.6%
Q4 FY2024	$24.11B	$55.89B	$50.32B	$180.10B	$108.61B	$36.65B	$71.49B	+17.1%
Q3 FY2024	$19.98B	$53.25B	$51.76B	$178.29B	$108.13B	$31.29B	$70.16B	-1.1%

Cash flow

Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.

8 / 20 Quarterly

Period	Operating cash flow	CapEx	Free cash flow	Net income	Dividends paid	Buybacks	FCF QoQ
Q2 FY2026				$5.53B
Q1 FY2026				$5.24B
Q4 FY2025				$5.12B
Q3 FY2025				$5.15B
Q2 FY2025				$5.54B
Q1 FY2025				$11.00B
Q4 FY2024	$6.98B	$1.61B	$5.37B	$3.43B	$2.98B	$282.00M	-22.9%
Q3 FY2024	$7.99B	$1.03B	$6.96B	$2.69B	$2.98B	$539.00M	+49.5%

Valuation and returns

Enterprise value: $656.03B; Market data source

Return on equity: 25.74%; Market data source

Return on assets: 10.46%; Market data source

Debt / equity: 0.44; Current ratio 1.09

Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.

Annual revenue and income multiples

Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.

Annual revenue base: $94.19B; Annual statement 2025-12-28

Annual income base: $26.80B; Annual statement 2025-12-28

Market cap / annual revenue: 7.03; Live market value divided by annual revenue

Market cap / annual income: 24.69; Live market value divided by annual net income

Annual sales and income multiple

EV / annual revenue6.96

Market capitalization bridge

Market cap / annual revenue7.03

Market cap / annual income24.69

TTM valuation multiples

TTM revenue: $97.93B; Trailing twelve months

Market cap / TTM revenue: 6.76; Live market value divided by trailing twelve months revenue

EV / TTM revenue: 6.70; Enterprise value divided by trailing twelve months revenue

Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.

Profit multiples

Market cap / TTM net income31.46

Revenue, net income, and free cash flow

Revenue$25.31BNet income$5.53B

Q1 FY2025Q4 FY2025Q2 FY2026

Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.

Efficiency

Growth vs cost pressure

Revenue growth YoY+6.6%

Debt growth YoY-4.8%

Quarterly margin heatmap

Gross margin

Q1 FY2025

66.40%

Q2 FY2025

67.87%

Q3 FY2025

69.56%

Q4 FY2025

67.56%

Q1 FY2026

66.31%

Q2 FY2026

68.19%

Operating margin

Q1 FY2025

—

Q2 FY2025

—

Q3 FY2025

—

Q4 FY2025

—

Q1 FY2026

—

Q2 FY2026

—

Net margin

Q1 FY2025

50.24%

Q2 FY2025

23.32%

Q3 FY2025

21.47%

Q4 FY2025

20.83%

Q1 FY2026

21.76%

Q2 FY2026

21.86%

Latest quarter expense mix

Cost of revenue$8.05B

SG&A$6.43B

Profit bridge

Pretax income$6.75B

Tax expense$1.21B

Other income statement lines

Income before tax$6.75B

Income tax expense$1.21B

Balance sheet · Q2 FY2026

Cash & equivalents: $20.42B

Total debt: $37.34B

Net cash: -$16.92B; Net debt position

Total equity: $84.97B

Balance sheet detail

Current assets: $59.77B

Current liabilities: $54.90B

Inventory: $15.14B

Receivables: $19.05B

Property, plant & equipment: $23.58B

Long-term debt: $37.34B

Debt and liquidity

Debt / revenuei0.38

Debt / income1.78

Cash / debt0.55

Quick ratioi0.72

Cash + short-term investments + receivables / current liabilities

Cash generation

Frequently asked

Common questions.

What financial data is available for JNJ?

The JNJ Financials page renders only the current income-statement, balance-sheet, cash-flow, or fund rows supplied for Johnson & Johnson. Missing modules and empty line items are omitted.

How current are JNJ's financial statements?

Each visible statement row keeps its reported period and provider attribution. The route redirects to the main quote when no usable financial or fund data remains.

What is Johnson & Johnson's reported net margin?

Johnson & Johnson's fresh reported margin field is 21.48%. The Financials page shows the supporting period data currently available for JNJ.